About
MapLight Therapeutics is a clinical-stage biopharmaceutical company based in Redwood City, California. It focuses on discovering and developing targeted therapies for central nervous system disorders by leveraging proprietary neurocircuitry mapping and precision pharmacology. Its programs address unmet needs across psychiatric and neurological conditions, including schizophrenia and Alzheimer’s disease psychosis.
The company utilizes an integrated discovery platform to rapidly translate insights from foundational neurobiology through preclinical and clinical development.
